H2 EV/FCF

Mitä H2 tekee? H2 Inc is a company based in George Town, Grand Cayman, operating in the healthcare technology sector. The company employs 146 full-time staff and is set to undergo an initial public offering (IPO) on November 19, 2025. H2 Inc provides personalized healthcare solutions through data analytics, focusing on patient-centered care. The company's offerings include a mobile application and a patient management platform, both designed to support chronic disease management. The Health2Sync App enables users to record health data, track long-term trends, review historical information, and share reports with healthcare providers. It also offers reminder features and care coordination with partner organizations. A premium membership tier provides enhanced data analysis and educational resources. The Patient Management Platform facilitates rapid deployment, patient prioritization, data-driven insights, and improved communication channels. The company supports integration with various health monitoring devices and applications, including blood glucose meters, blood pressure monitors, weight scales, insulin pens, continuous glucose monitors (CGMs), and compatible health apps. H2 Inc's technology aims to streamline healthcare management for individuals with chronic conditions through digital tools and data synchronization. The company's headquarters are located in George Town, Grand Cayman, and it operates under the ticker symbol 7851.TWO with ISIN KYG4711S1030. The company's website is https://www.health2sync.com/. H2 on yksi Eurpooliin suosituimmista yhtiöistä.